Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study.

Briggs, A. et al. (2007) Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart, 93(9), pp. 1081-1086.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Briggs, Professor Andrew
Authors: Briggs, A., Mihaylova, B., Sculpher, M., Hall, A., Wolstenholme, J., Simoons, M., Deckers, J., Ferrari, R., Remme, W., Bertrand, M., and Fox, K.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Health Economics and Health Technology Assessment
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Centre for Population and Health Sciences
Journal Name:Heart

University Staff: Request a correction | Enlighten Editors: Update this record